Posted on March 31st, 2010 by Health News
GeoVax Labs, Inc., a biotechnology company that creates, develops, and tests innovative HIV/AIDS vaccines, is now allowed by the FDA to begin a phase 1 clinical trial for GeoVax’s therapeutic vaccine, which is intended as a treatment for individuals infected with HIV. The company will begin a non-blinded study in HIV infected individuals who started [...]
No Comments »
Filed under: Pharmacy News
Posted on March 31st, 2010 by Health News
NovaBay Pharmaceuticals, Inc., a clinical stage specialty pharmaceutical company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today reported full-year and fourth quarter financial results for 2009. The company also highlighted recent progress of its proprietary and partnered development programs.
No Comments »
Filed under: Pharmacy News
Posted on March 31st, 2010 by Health News
Oncolytics Biotech Inc. announced today that the Cancer Therapy & Research Center at the University of Texas Health Science Center has started patient enrolment in a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with carboplatin and paclitaxel in patients with squamous cell carcinoma of the lungs.
No Comments »
Filed under: Pharmacy News
Posted on March 31st, 2010 by Health News
Clinical Data, Inc., today announced results from two Phase I studies of Stedivaze™ (apadenoson), which demonstrated that Stedivaze was safe and well tolerated in patients with asthma and chronic obstructive pulmonary disease (COPD). Stedivaze is a potent and highly selective agonist of the adenosine A2A receptor subtype in development as a pharmacologic stress agent for [...]
No Comments »
Filed under: Pharmacy News
Posted on March 31st, 2010 by Health News
The Legal Assault on Health Reforms The New York Times No sooner had President Obama signed comprehensive health care reform than the attorneys general of 14 states scurried to the federal courts to challenge the law. …
No Comments »
Filed under: Pharmacy News
Posted on March 31st, 2010 by Health News
The Associated Press: Under the new health care law, “pharmaceutical lobbyists won new federal policies they coveted and set a trajectory for long-term industry growth.” Ramsey Baghdadi, a Washington health policy analyst, “projects a $30 billion, 10-year net gain for the industry. ‘I don’t see how they could have done much better,’” he said…
No Comments »
Filed under: Pharmacy News
Posted on March 31st, 2010 by Health News
GenVec, Inc. (Nasdaq: GNVC) announced that it is discontinuing its Phase 3 clinical trial of TNFerade™ in patients with locally advanced pancreatic cancer based on results of an interim analysis. This interim analysis of overall survival, conducted after the 184th death (two-thirds of total expected events), was designed to determine whether the study should continue…
No Comments »
Filed under: Pharmacy News
Posted on March 31st, 2010 by Health News
Cephalon, Inc. (Nasdaq: CEPH) announced the company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for its supplemental new drug application for NUVIGIL® (armodafinil) Tablets [C-IV] in the treatment of patients with excessive sleepiness associated with jet lag disorder resulting from eastbound travel…
No Comments »
Filed under: Pharmacy News
Posted on March 31st, 2010 by Health News
Trius Therapeutics, Inc. announced results from its Phase 1 clinical trial evaluating the safety, tolerability and pharmacokinetics of the intravenous (IV) dosage form of torezolid phosphate, an IV and orally administered second generation oxazolidinone for the treatment of serious gram positive infections, including methicillin-resistant Staphylococcus aureus (MRSA)…
No Comments »
Filed under: Pharmacy News
Posted on March 31st, 2010 by Health News
Enobia Pharma Inc. unveiled findings from the first hypophosphatasia (HPP) self-reported patient survey intended to evaluate the burden of illness associated with HPP at the 2010 American College of Medical Genetics (ACMG) Annual Clinical Genetics Meeting…
No Comments »
Filed under: Pharmacy News
